US-based medicine company Eli Lilly to invest $3B in a new manufacturing facility in the Netherlands to expand production and ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, tolerabilit ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ProQR ( (PRQR) ) has issued an ...

Eli Lilly (LLY) said on Thursday that eloralintide, its experimental amylin receptor agonist for obesity, helped patients ...

The following segment was excerpted from the Artisan Global Opportunities Fund Q3 2025 Commentary. During the quarter, we initiated new positions in Spotify, L3Harris Technologies and Insmed. Spotify ...